The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Open accessAbstract
We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative demethylation activity targeting the abundant N6-methyladenosine (m(6)A) residues in RNA in vitro. FTO knockdown with siRNA led to increased amounts of m(6)A in mRNA, whereas overexpression of FTO resulted in decreased amounts of m(6)A in human cells. We further show the partial colocalization of FTO with nuclear speckles, which supports the notion that m(6)A in nuclear RNA is a major physiological substrate of FTO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The m6A modification can be removed by erasers, mainly FTO and ALKBH5 [24,25].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [24]
In the citing paper
“Although evidence points to an oncogenic role of FTO in AML 15 ,”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [15]
In the citing paper
“In addition to TET enzymes, D2HG can inhibit the N6-methyladenosine (m6A) RNA demethylase fat mass and obesity associated protein (FTO), another α -KG-dependent dioxygenase 15 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,633
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,095
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Variation in FTO contributes to childhood obesity and severe adult obesity
Dina, C., Meyre, D., Gallina, S., Durand, E., Körner, A., Jacobson, P., Carlsson, L. M. S., Kieß, W., Vatin, V., Lecœur, C., et al. (2007) · Nature Genetics · doi:10.1038/ng2048 · Cited by 1,648
The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase
Gerken, T., Girard, C. A. J., Tung, Y. L., Webby, C. J., Saudek, V., Hewitson, K. S., Yeo, G. S. H., McDonough, M. A., Cunliffe, S. L., McNeill, L. A., et al. (2007) · Science · doi:10.1126/science.1151710 · Cited by 1,541
Self-citationThorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius, S., Jonsdottir, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.274 · Cited by 1,375
Nuclear speckles: a model for nuclear organelles
Lamond, A. I., & Spector, D. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1172 · Cited by 1,002
Inactivation of the Fto gene protects from obesity
Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J. C., & Rüther, U. (2009) · Nature · doi:10.1038/nature07848 · Cited by 964
Bokar, J. A., Shambaugh, M. E., Polayes, D. A., Matera, A. G., & ROTTMAN, F. M. (1997) · PubMed Central · Cited by 955
Flagged first, then by citations
Research works printed but not linked: 1
- Bokar, J.A., Shambaugh, M.E., Polayes, D., Matera, A.G. & Rottman, F.M. RNA 3, 1233–1247 (1997).
Cited by
Sorted by citations
Items 301–400 of 1,011
Widespread occurrence of N 6 -methyladenosine in bacterial mRNA
Deng, X., Chen, K., Luo, G., Weng, X., Ji, Q., Zhou, T., & He, C. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv596 · Cited by 219
Self-citationNi, Z., Sun, P., Zheng, J., Wu, M., Yang, C., Cheng, M., Yin, M., Cui, C., Wang, G., Yuan, L., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1323 · Cited by 221
Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., et al. (2021) · Blood · doi:10.1182/blood.2020009676 · Cited by 213
A metabolic labeling method detects m6A transcriptome-wide at single base resolution
Shu, X., Cao, J., Cheng, M., Xiang, S., Gao, M., Li, T., Ying, X., Wang, F., Yue, Y., Lu, Z., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0526-9 · Cited by 219
Self-citationZhou, K. I., Parisien, M., Dai, Q., Liu, N., Diatchenko, L. B., Sachleben, J. R., & Pan, T. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.021 · Cited by 217
Self-citationThe human NAD metabolome: Functions, metabolism and compartmentalization
Nikiforov, A. A., Kulikova, V., & Ziegler, M. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1028612 · Cited by 221
Huang, J., Sun, W., Wang, Z., Lv, C., Zhang, T., Zhang, D., Dong, W., Shao, L., He, L., Ji, X., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02254-z · Cited by 198
Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death
Chen, X., Yu, C., Guo, M., Zheng, X., Ali, S., Huang, H., Zhang, L., Wang, S., Huang, Y., Qie, S., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00657 · Cited by 212
Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes
Koh, C. W. Q., Goh, Y. T., & Goh, W. S. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13561-z · Cited by 208
Targeting the RNA m6A modification for cancer immunotherapy
Li, X., Ma, S., Deng, Y., Yi, P., & Yu, J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01558-0 · Cited by 212
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates
Liu, X., Zhou, J. L., Mao, Y., Ji, Q., & Qian, S. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0327-1 · Cited by 211
“The discovery of FTO and ALKBH5 in the demethylation pathway suggests the dynamic feature of m 6 A modification 6,7 .”
Antibody-free enzyme-assisted chemical approach for detection of N6-methyladenosine
Wang, Y., Xiao, Y., Dong, S., Yu, Q., & Jia, G. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0525-x · Cited by 213
Self-citationN6-methyl-adenosine modification in messenger and long non-coding RNA
Pan, T. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.12.006 · Cited by 208
Self-citationFTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms
Azzam, S. K., AlSafar, H. S., & Sajini, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073800 · Cited by 211
Mapping recently identified nucleotide variants in the genome and transcriptome
Song, C., Yi, C., & He, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2398 · Cited by 202
Self-citationTime-resolved protein activation by proximal decaging in living systems
Wang, J., Liu, Y., Liu, Y., Zheng, S., Wang, X., Zhao, J., Yang, F., Zhang, G., Wang, C., & Chen, P. R. (2019) · Nature · doi:10.1038/s41586-019-1188-1 · Cited by 203
Gu, C., Wang, Z., Zhou, N., Li, G., Kou, Y., Luo, Y., Wang, Y., Yang, J., & Tian, F. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1084-1 · Cited by 205
“On the contrary, FTO and AlkBH5 induce m(6)A demethylases [16, 17].”
Chemical and structural effects of base modifications in messenger RNA
Harcourt, E. M., Kietrys, A. M., & Kool, E. T. (2017) · Nature · doi:10.1038/nature21351 · Cited by 201
Yang, Z., Yu, G.-L., Zhu, X., Peng, T., & Lv, Y.-C. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.01.005 · Cited by 209
Reversible RNA ModificationN1-Methyladenosine (m1A) in mRNA and tRNA
Zhang, C., & Jia, G. (2018) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.03.003 · Cited by 209
Self-citationRole of N6-methyladenosine modification in cancer
Deng, X., Su, R. J., Feng, X., Wei, M., & Chen, J. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.005 · Cited by 198
Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition
Feng, C., Liu, Y., Wang, G., Deng, Z., Zhang, Q., Wu, W., Tong, Y., Cheng, C., & Chen, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.546168 · Cited by 202
iRNA(m6A)-PseDNC: Identifying N6-methyladenosine sites using pseudo dinucleotide composition
Chen, W., Ding, H., Zhou, X., Lin, H., & Chou, K. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.09.002 · Cited by 199
N 6-methyladenosine modification and METTL3 modulate enterovirus 71 replication
Hao, H., Hao, S., Chen, H., Chen, Z. B., Zhang, Y., Wang, J., Wang, H., Zhang, B., Qiu, J., Dèng, F., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1007 · Cited by 202
Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation
Sun, H., Zhu, A. C., Gao, Y., Terajima, H., Fei, Q., Liu, S., Zhang, L., Zhang, Z. S., Harada, B. T., He, Y., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.026 · Cited by 198
Self-citationShen, F., Huang, W., Huang, J.-T., Xiong, J., Yang, Y., Wu, K., Jia, G.-F., Chen, J., Feng, Y., Yuan, B., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1893 · Cited by 198
Self-citationThe m6A pathway facilitates sex determination in Drosophila
Kan, L., Grozhik, A. V., Vedanayagam, J., Patil, D. P., Pang, N., Lim, K.-S., Huang, Y., Joseph, B. J., Lin, C., Despic, V., et al. (2017) · Nature Communications · doi:10.1038/ncomms15737 · Cited by 203
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00484-x · Cited by 199
Self-citationXu, C., Liu, K., Tempel, W., Demetriades, M., Aik, W. S., Schofield, C. J., & Min, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550350 · Cited by 198
Song, P., Yang, J., Wang, C., Lu, Q., Shi, L., Tayier, S., & Jia, G. (2021) · Molecular Plant · doi:10.1016/j.molp.2021.01.014 · Cited by 197
Self-citationN6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation
Gu, X., Zhang, Y., Li, D., Cai, H., Cai, L., & Xu, Q. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109553 · Cited by 194
Zhou, B., Liu, C., Xu, L., Yuan, Y., Zhao, J., Zhao, W., Chen, Y., Qiu, J., Meng, M., Zheng, Y. F., et al. (2020) · Hepatology · doi:10.1002/hep.31220 · Cited by 196
Mechanisms of human histone and nucleic acid demethylases
Walport, L. J., Hopkinson, R. J., & Schofield, C. J. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.09.015 · Cited by 194
Jin, H., Ying, X., Que, B., Wang, X., Chao, Y., Zhang, H., Yuan, Z., Qi, D., Lin, S., Wang, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.068 · Cited by 195
Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation
Wang, Q., Tan, K., Wang, H., Shang, J., Wan, Y., Liu, X., Weng, X., & Wang, F. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00570 · Cited by 192
Structure and Function of Noncanonical Nucleobases
Carell, T., Brandmayr, C., Hienzsch, A., Müller, M., Pearson, D., Reiter, V., Thoma, I., Thumbs, P., & Wagner, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201193 · Cited by 200
m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation
Jia, R., Chai, P., Wang, S., Sun, B., Xu, Y., Yang, Y., Ge, S., Jia, R., Yang, Y., & Fan, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1088-x · Cited by 193
“*p < 0.05, ***p < 0.001. d Kaplan-Meier curves of tumor recurrence showing the difference between ocular melanoma patients with low and high METTL3 levels. n = 54, log rank test, p < 0.05. e The expression of METTL3 in patients at AJCC stages T1 to T4. f Kaplan-Meier curves of tumor recurrence showing the difference b…”
BackgroundInfluentialSelf-citationFormation and Abundance of 5‐Hydroxymethylcytosine in RNA
Huber, S. M., van Delft, P., Mendil, L., Bachman, M., Smollett, K. L., Werner, F., Miska, E. A., & Balasubramanian, S. (2015) · ChemBioChem · doi:10.1002/cbic.201500013 · Cited by 187
m6AVar: a database of functional variants involved in m6A modification
Zheng, Y., Nie, P., Peng, D., He, Z., Liu, M., Xie, Y., Miao, Y., Zuo, Z., & Ren, J. M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx895 · Cited by 189
m 6 A demethylase ALKBH5 controls CD4 + T cell pathogenicity and promotes autoimmunity
Zhou, J., Zhang, X., Hu, J., Qu, R., Yu, Z., Xu, H. Y., Chen, H., Yan, L., Ding, C., Zou, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg0470 · Cited by 191
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
Zheng, Y., Ma, J., Wang, Z., Li, J., Jiang, B., Zhou, W., Shi, X., Wang, X., Zhao, W., & Liu, H. (2015) · Medicinal Research Reviews · doi:10.1002/med.21350 · Cited by 196
FTO and Obesity: Mechanisms of Association
Zhao, X., Yang, Y., Sun, B.-F., Zhao, Y.-L., & Yang, Y. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0486-0 · Cited by 193
Self-citationZhang, Z. S., Luo, K., Zou, Z., Qiu, M., Tian, J., Sieh, L., Shi, H., Zou, Y., Wang, G., Morrison, J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0644-z · Cited by 192
“Levels of m 6 A are controlled by both m 6 A writers – in particular the METTL3/14 complex 13,14 – and erasers, such as ALKBH5 15 and FTO 16,17 .”
Self-citationHou, G., Zhao, X., Li, L., Yang, Q., Liu, X., Huang, C., Lu, R., Chen, R., Wang, Y., Jiang, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab065 · Cited by 189
Self-citationThe role of m6A modification in physiology and disease
Yang, C., Hu, Y., Zhou, B., Bao, Y., Li, Z., Gong, C., Yang, H., Wang, S., & Xiao, Y. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03143-z · Cited by 200
Selberg, S., Blokhina, D., Aatonen, M., Koivisto, P., Siltanen, A., Mervaala, E. M. A., Kankuri, E. M., & Karelson, M. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.100 · Cited by 183
Li, B., Jiang, J., Assaraf, Y. G., Xiao, H., Chen, Z., & Huang, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100720 · Cited by 190
LncRNAs: key players and novel insights into cervical cancer
Peng, L., Yuan, X., Jiang, B., Tang, Z., & Li, G. (2015) · Tumor Biology · doi:10.1007/s13277-015-4663-9 · Cited by 187
iRNA-3typeA: Identifying Three Types of Modification at RNA’s Adenosine Sites
Chen, W., Feng, P., Yang, H. Q., Ding, H., Lin, H., & Chou, K. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.03.012 · Cited by 186
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Xue, C., Chu, Q., Zheng, Q., Jiang, S., Bao, Z., Su, Y., Lü, J., & Li, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01003-0 · Cited by 192
Feng, Z., Li, Q., Meng, R., Yi, B., & Xu, Q. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13491 · Cited by 181
Yang, F., Jin, H., Que, B., Chao, Y., Zhang, H., Ying, X., Zhou, Z., Yuan, Z., Su, J., Wu, B., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0755-0 · Cited by 183
Xia, Q., & Grant, S. F. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12020 · Cited by 191
The RNA Modification N 6 -Methyladenosine and Its Implications in Human Disease
Batista, P. J. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.03.002 · Cited by 187
Han, H., Gao, F., Song, S., Jiang, Y., Qian, C., Zhang, W., Su, Q., Xue, X., Zhuang, W., & Li, B.-Z. (2020) · Blood · doi:10.1182/blood.2019003764 · Cited by 181
RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer
Li, W., Deng, X., & Chen, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.025 · Cited by 189
The RNA N6-methyladenosine modification landscape of human fetal tissues
Xiao, S., Cao, S., Huang, Q., Xia, L., Deng, M., Yang, M., Jia, G., Liu, X., Shi, J., Wang, W., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0315-4 · Cited by 180
Self-citationThe FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer
Xu, Y., Ye, S., Zhang, N., Zheng, S., Liu, H., Zhou, K., Wang, L., Cao, Y., Sun, P., & Wang, T. (2020) · 癌症:英文版 · doi:10.1002/cac2.12075 · Cited by 180
Li, J., Meng, S., Xu, M., Wang, S., He, L., Xu, X., Wang, X., & Xie, L. (2017) · Oncotarget · doi:10.18632/oncotarget.23365 · Cited by 175
Iyer, L. M., Zhang, D., & Aravind, L. (2015) · BioEssays · doi:10.1002/bies.201500104 · Cited by 183
Haruehanroengra, P., Zheng, Y. Y., Zhou, Y., Huang, Y., & Sheng, J. (2020) · RNA Biology · doi:10.1080/15476286.2020.1722449 · Cited by 178
The ‘Fat Mass and Obesity Related’ (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance
Speakman, J. R. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0143-1 · Cited by 190
Small‐Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer
Bedi, R. K., Danzhi Huang, A., Eberle, S. A., Wiedmer, L., Śledź, P., & Caflisch, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000011 · Cited by 174
Role for the obesity-related FTO gene in the cellular sensing of amino acids
Gulati, P., Cheung, M.-K. M., Antrobus, R., Church, C. D., Harding, H. P., Tung, Y. L., Rimmington, D., Ma, M. K. L., Ron, D., Lehner, P. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222796110 · Cited by 171
Kobayashi, M., Ohsugi, M., Sasako, T., Awazawa, M., Umehara, T., Iwane, A., Kobayashi, N., Okazaki, Y., Kubota, N., Suzuki, R., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00116-18 · Cited by 170
Chen, X., Xu, M., Xu, X., Zeng, K., Liu, X., Sun, L., Pan, B., He, B., Pan, Y., Sun, H., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.016 · Cited by 171
RetractedFan, Z., Yang, G., Zhang, W., Liu, Q., Liu, G., Liu, P., Xu, L., Wang, J., Yan, Z., Han, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16957 · Cited by 170
Epigenetic modification of m6A regulator proteins in cancer
Wang, Y., Wang, Y., Patel, H. H., Chen, J., Wang, J., Chen, Z., & Wang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01810-1 · Cited by 178
Liu, W.-W., Zheng, S.-Q., Tian, L., Fei, Y.-F., Wang, C., Zhang, S., Wang, F., Jiang, G., & Wang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01777-5 · Cited by 187
Epitranscriptomics in liver disease: Basic concepts and therapeutic potential
Zhao, Z., Meng, J., Su, R. J., Zhang, J., Chen, J., Ma, X., & Xia, Q. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.009 · Cited by 166
m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells
Huff, S. E., Tiwari, S. K., Gonzalez, G. M., Wang, Y., & Rana, T. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00841 · Cited by 173
The m6A methylome of SARS-CoV-2 in host cells
Liu, J., Xu, Y., Li, K., Ye, Q., Zhou, H.-Y., Sun, H., Li, X., Yu, L., Deng, Y., Li, R.-T., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00465-7 · Cited by 170
Self-citationThe Biology of m6A RNA Methylation in Normal and Malignant Hematopoiesis
Vu, L., Cheng, Y., & Kharas, M. G. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0959 · Cited by 168
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
Relier, S., Ripoll, J., Guillorit, H., Amalric, A., Achour, C., Boissière‐Michot, F., Vialaret, J., Attina, A., Debart, F., Choquet, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21758-4 · Cited by 168
Chemical Modifications to RNA: A New Layer of Gene Expression Regulation
Song, J., & Yi, C. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b00960 · Cited by 167
Self-citationXie, W., Ma, L. L., Xu, Y., Wang, B. H., & Li, S. M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.018 · Cited by 167
FTO – A Common Genetic Basis for Obesity and Cancer
Lan, N., Lu, Y., Zhang, Y., Pu, S., Xi, H., Nie, X., Liu, J., & Yuan, W. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.559138 · Cited by 176
The Roles of Jumonji-Type Oxygenases in Human Disease
Johansson, C., Tumber, A., Che, K., Cain, P., Nowak, R. P., Gileadi, C., & Oppermann, U. C. T. (2014) · Epigenomics · doi:10.2217/epi.13.79 · Cited by 167
Hoernes, T. P., Clementi, N., Faserl, K., Glasner, H., Breuker, K., Lindner, H. H., Hüttenhofer, A., & Erlacher, M. D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1182 · Cited by 166
“Interestingly, m6A has been found to be enzymatically eliminated from mRNAs, implicating m6A to be a dynamic regulator of gene expression (20).”
The Epitranscriptome of Noncoding RNAs in Cancer
Esteller, M., & Pandolfi, P. P. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1292 · Cited by 168
“FTO was also found to be overexpressed in human breast cancer samples.”
BackgroundInfluentialXu, H., Wang, H., Zhao, W., Fu, S., Li, Y., Ni, W., Xin, Y., Li, W., Yang, C., Bai, Y., et al. (2020) · Theranostics · doi:10.7150/thno.42539 · Cited by 166
The proteins of mRNA modification: writers, readers, and erasers
Flamand, M. N., Tegowski, M., & Meyer, K. D. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-035330 · Cited by 164
Mei, L., Shen, C., Miao, R., Wang, J., Cao, M.-D., Zhang, Y., Shi, L., Guo-hai, Z., Wang, M.-H., Wu, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2487-z · Cited by 165
Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer’s Disease
Huang, H., Camats‐Perna, J., Medeiros, R., Anggono, V., & Widagdo, J. (2020) · eNeuro · doi:10.1523/eneuro.0125-20.2020 · Cited by 164
Li, Y., Wang, X., Li, C., Hu, S., Yu, J. M., & Song, S. (2014) · RNA Biology · doi:10.4161/rna.36281 · Cited by 164
Wang, X., Huang, N., Yang, M., Wei, D., Tai, H., Han, X., Gong, H., Zhou, J., Qin, J., Wei, X., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.122 · Cited by 167
Tan, B., Liu, H., Zhang, S., da Silva, S. R., Zhang, L., Meng, J., Cui, X., Yuan, H., Sorel, O., Zhang, S., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0056-8 · Cited by 164
m6A modification in RNA: biogenesis, functions and roles in gliomas
Zhang, Y., Geng, X., Li, Q., Xu, J., Tan, Y., Xiao, M., Song, J., Liu, F., Fang, C., & Wang, H. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01706-8 · Cited by 163
“After fat mass and obesity-associated gene (FTO) knockdown, the m6A level in mRNA increases [31].”
BackgroundRNA methylations in human cancers
Han, X., Wang, M., Zhao, Y., Yang, Y., & Yang, Y. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.007 · Cited by 159
Self-citationStructural Basis for Inhibition of the Fat Mass and Obesity Associated Protein (FTO)
Aik, W. S., Demetriades, M., Hamdan, M. K. K., Bagg, E. A. L., Yeoh, K. K., Lejeune, C., Zhang, Z., McDonough, M. A., & Schofield, C. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400193d · Cited by 162
Dynamic RNA Modifications in Posttranscriptional Regulation
Wang, X., & He, C. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.001 · Cited by 162
“Hence, it is not surprising that 20-O-methylation has been widely incorporated into small interference RNA (siRNA) 8 Molecular Cell 56, October 2, 2014 ª2014 Elsevier Inc. to optimize the stability and immunogenic properties of siRNA (Judge et al., 2006).”
Self-citationLiu, X., Liu, J., Xiao, W., Zeng, Q., Bo, H., Zhu, Y., Gong, L., He, D., Xing, X., Li, R., et al. (2020) · Hepatology · doi:10.1002/hep.31222 · Cited by 162
Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Zhang, M., Song, J., Yuan, W., Zhang, W., & Sun, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641507 · Cited by 162
DNA Repair by Reversal of DNA Damage
Yi, C., & He, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012575 · Cited by 161
Self-citationRNA epigenetics — chemical messages for posttranscriptional gene regulation
Roundtree, I. A., & He, C. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.10.024 · Cited by 161
Self-citationSheng, H., Li, Z., Su, S., Sun, W., Zhang, X., Li, L., Li, J., Liu, S., Lü, B., Zhang, S., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz152 · Cited by 161
Jiang, F., Tang, X., Tang, C., Hua, Z., Ke, M., Wang, C., Zhao, J., Gao, S., Jurczyszyn, A. J., Janz, S., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01066-6 · Cited by 161
Self-citationChang, M., Lv, H., Zhang, W., Ma, C., He, X., Zhao, S., Zhang, Z.-W., Zeng, Y., Song, S., Niu, Y., et al. (2017) · Open Biology · doi:10.1098/rsob.170166 · Cited by 158
Deng, R., Cheng, Y., Ye, S., Zhang, J., Huang, R., Li, P., Liu, H., Deng, Q., Wu, X., Lan, P., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201052 · Cited by 160
Zhao, Y., Hu, J., Sun, X., Yang, K., Yang, L., Kong, L., Zhang, B., Li, F., Li, C., Shi, B., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.402 · Cited by 161
Metadata
- Authors
- Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., & He, C.
- Affiliations
- University of Chicago (US)
- Chinese Academy of Sciences (CN)
- Cancer Research UK (GB)
- Corresponding author
- He, Chuan
- Venue
- Nature Chemical Biology
- Published
- 2011-10-16
- Volume
- 7
- Issue
- 12
- Pages
- 885-887
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC3218240
- OpenAlex
- W2071930821
- Cited by
- 4,106
- References
- 27
- Citations by year
- 2026: 272 · 2025: 416 · 2024: 473 · 2023: 489 · 2022: 546 · 2021: 544 · 2020: 341 · 2019: 217 · 2018: 218 · 2017: 159 · 2016: 109 · 2015: 107 · 2014: 94 · 2013: 67 · 2012: 45
- FWCI
- 26.98
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-11-26)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (GM071440, R01GM071440, R01GM088599, GM088599)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- N6-methyladenosine, m6A demethylation, FTO, nuclear RNA, RNA modification, oxidative demethylation, nuclear speckles, obesity, RNA metabolism
- MeSH terms
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Adenosine, Cell Nucleus, HeLa Cells, Humans, Methylation, Obesity, Oxidation-Reduction, Proteins, RNA, Messenger, Substrate Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review